OpGen Technologies, Inc. Announces Argus Optical Mapping System Purchase by Wellcome Trust Sanger Institute

(BUSINESS WIRE)--OpGen, Inc., a commercial phase genomics and DNA analysis company, today announced that the Wellcome Trust Sanger Institute has purchased an Argus™ Optical Mapping System in order to reduce the time and cost of whole genome sequence assembly.

Back to news